Focus
Guillain-Barré syndrome
Certain COVID-19 Vaccines Linked to Elevated Risk of Guillain-Barré Syndrome
As the rate of vaccination increases so has the incidence of GBS—particularly after viral vector-based vaccines such as AstraZeneca.
Rare Disease Erupts in Peru; WHO to Authenticate Health Records; Surprising Habits That Damage Liver
